These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12475197)

  • 21. Involvement of cysteine protease inhibitors in the defense mechanism against parasites.
    Izuhara K; Kanaji S; Arima K; Ohta S; Shiraishi H
    Med Chem; 2008 Jul; 4(4):322-7. PubMed ID: 18673143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the synthesis, design and selection of cysteine protease inhibitors.
    Hernandez AA; Roush WR
    Curr Opin Chem Biol; 2002 Aug; 6(4):459-65. PubMed ID: 12133721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteases of Plasmodium falciparum as potential drug targets and inhibitors thereof.
    Wegscheid-Gerlach C; Gerber HD; Diederich WE
    Curr Top Med Chem; 2010; 10(3):346-67. PubMed ID: 20166950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vinyl sulfonium as novel proteolytic enzyme inhibitor.
    Zhao G; Zhou ZS
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2331-5. PubMed ID: 11527725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases.
    Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB
    J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of cysteine proteases.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of cysteine proteases by (acyloxy)methyl ketones using S'-P' interactions.
    Dai Y; Hedstrom L; Abeles RH
    Biochemistry; 2000 May; 39(21):6498-502. PubMed ID: 10828965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of selective and nonpeptidic cathepsin S inhibitors.
    Irie O; Ehara T; Iwasaki A; Yokokawa F; Sakaki J; Hirao H; Kanazawa T; Teno N; Horiuchi M; Umemura I; Gunji H; Masuya K; Hitomi Y; Iwasaki G; Nonomura K; Tanabe K; Fukaya H; Kosaka T; Snell CR; Hallett A
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3959-62. PubMed ID: 18572405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases.
    Asgian JL; James KE; Li ZZ; Carter W; Barrett AJ; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2002 Nov; 45(23):4958-60. PubMed ID: 12408706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of dipeptidyl alpha',beta'-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain.
    Roush WR; González FV; McKerrow JH; Hansell E
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2809-12. PubMed ID: 9873627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases.
    Sadaghiani AM; Verhelst SH; Gocheva V; Hill K; Majerova E; Stinson S; Joyce JA; Bogyo M
    Chem Biol; 2007 May; 14(5):499-511. PubMed ID: 17524981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of parasite cysteine proteinase inactivation by NO-donors.
    Bocedi A; Gradoni L; Menegatti E; Ascenzi P
    Biochem Biophys Res Commun; 2004 Mar; 315(3):710-8. PubMed ID: 14975759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases.
    Löser R; Frizler M; Schilling K; Gütschow M
    Angew Chem Int Ed Engl; 2008; 47(23):4331-4. PubMed ID: 18404765
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and evaluation of chloromethyl sulfoxides as a new class of selective irreversible cysteine protease inhibitors.
    Brouwer AJ; Bunschoten A; Liskamp RM
    Bioorg Med Chem; 2007 Nov; 15(22):6985-93. PubMed ID: 17869119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors.
    Meara JP; Rich DH
    J Med Chem; 1996 Aug; 39(17):3357-66. PubMed ID: 8765519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors.
    Ehmke V; Quinsaat JE; Rivera-Fuentes P; Heindl C; Freymond C; Rottmann M; Brun R; Schirmeister T; Diederich F
    Org Biomol Chem; 2012 Aug; 10(30):5764-8. PubMed ID: 22336919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series.
    Coterón JM; Catterick D; Castro J; Chaparro MJ; Díaz B; Fernández E; Ferrer S; Gamo FJ; Gordo M; Gut J; de las Heras L; Legac J; Marco M; Miguel J; Muñoz V; Porras E; de la Rosa JC; Ruiz JR; Sandoval E; Ventosa P; Rosenthal PJ; Fiandor JM
    J Med Chem; 2010 Aug; 53(16):6129-52. PubMed ID: 20672841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2/3 inhibitors.
    Verissimo E; Berry N; Gibbons P; Cristiano ML; Rosenthal PJ; Gut J; Ward SA; O'Neill PM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4210-4. PubMed ID: 18554905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
    Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
    Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.